WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Receives New Coverage from Analysts at Sanford C. Bernstein

Stock analysts at Sanford C. Bernstein assumed coverage on shares of WuXi Biologics (Cayman) (OTCMKTS:WXXWYGet Rating) in a report issued on Tuesday, The Fly reports. The brokerage set an “outperform” rating on the stock.

WuXi Biologics (Cayman) stock opened at $13.73 on Tuesday. The stock has a 50-day simple moving average of $15.37 and a 200 day simple moving average of $21.20. WuXi Biologics has a 12-month low of $10.50 and a 12-month high of $38.00.

About WuXi Biologics (Cayman) (Get Rating)

WuXi Biologics (Cayman) Inc, an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sales of medicals; vaccine CDMO and related business; and material supplier activities.

Further Reading

The Fly logo

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.